P2–402: Double–blind, placebo–controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

P2–402: Double–blind, placebo–controlled study of three different dosages of cerebrolysin in patients with mild to moderate Alzheimer's disease

Published:2006-07 Issue:3S_Part_12 Volume:2 Page:
ISSN:1552-5260
Container-title:Alzheimer's & Dementia
language:en
Short-container-title:Alzheimer's & Dementia

Author:

Alvarez Anton¹,Laredo Marta¹,Varela Miguel¹,Cacabelos Ramon¹,Sanpedro Carolina¹,Aleixandre Manuel²,Linares Carlos³,Moessler Herbert⁴

Affiliation:

1. Euroespes Biomedical Research CentreA CorunaSpain

2. Granada UniversityGranadaSpain

3. Memory ClinicMalagaSpain

4. Ebewa PharmaUnterachAustria

Publisher

Wiley

Subject

Psychiatry and Mental health,Cellular and Molecular Neuroscience,Geriatrics and Gerontology,Neurology (clinical),Developmental Neuroscience,Health Policy,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1016/j.jalz.2006.05.1243

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential of bone marrow mesenchymal stem cells in management of Alzheimer's disease in female rats;Cell Biology International;2014-07-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP